José C. Villasboas

机构：Toyota Motor Corporation (Switzerland), Mayo Clinic, Rochester Institute of Technology, Norton Healthcare, WinnMed, Mayo Clinic in Arizona, Mayo Clinic in Florida · ORCID：0000-0002-2907-0809

发表论文 318 篇 · 总被引 3059 次 · h-index 29

代表论文

• Fixed treatment duration subcutaneous mosunetuzumab monotherapy in elderly/unfit patients with previously untreated diffuse large B-cell lymphoma: Interim results from the Phase II MorningSun study (2025 · Blood · 被引 6)
• Fixed-duration subcutaneous mosunetuzumab demonstrates sustained clinically meaningful outcomes in patients with previously untreated, low-tumor burden follicular lymphoma (2025 · Blood · 被引 1)
• Bioflipi scores define distinct immune profiles in follicular lymphoma (2025 · Blood · 被引 1)
• The ratio of brain to liver glucose activity and prognosis with CAR-T in non-Hodgkin lymphoma (2025 · Blood Cancer Journal)
• Metabolic pathway signatures unpinning response to CD19 CAR T-cell therapy in aggressive B-cell non-Hodgkin's lymphoma (2025 · Blood)
• FLP-R: A clinical prediction model for follicular lymphoma Prognosis in the Relapsed/refractory setting (2025 · Blood)